A next wave of cancer treatments may combine immunotherapy and gene editing.
How a controversial Chinese cloning company burnishes its credentials with a prize.
Doctors at the University of Pennsylvania seek approval for gene editing to fight cancer.
The brain’s built-in protection system also prevents potentially lifesaving drugs from getting in, but maybe not for much longer.
To match cancer patients with drugs, one company plans to offer free genetic tests.
Spark Therapeutics is turning gene-therapy experiments into real drugs.
Eyeing eventual Mars mission, NASA plans first test of genetic diagnostics in space.
A startup says its technology can serve as an objective concussion test. The challenge is convincing people it works.
Too little is known about the risks of gene drives to responsibly release them in natural environments, say the authors of a new National Academies report.
To avoid missteps with a powerful genetic engineering technology that can modify species, one scientist demands total transparency.